Uncategorised - European Medical Journal

EHA 2025: CONCEPT Trial Shows Isatuximab Benefits High-Risk Myeloma

The Phase II CONCEPT trial has demonstrated that an isatuximab-based combination therapy achieves unprecedented rates of minimal residual disease negativity in patients with high-risk newly diagnosed multiple myeloma.

Mediterranean Diet Linked to Milder Crohn’s Disease and Healthier Gut Profile

A prospective study has found that the Mediterranean diet may help reduce inflammation and support a healthier gut microbiome in newly diagnosed Crohn’s disease patients.

Azithromycin Resistance in Gonorrhoea Surges Across Europe

Azithromycin resistance in gonorrhoea has surged across Europe, underscoring the urgent need for enhanced surveillance and new treatment options.

What HCPs want: Why interactive medical content works

Explore how interactive medical content empowers today’s HCPs to access the information they need in a faster, easier and more engaging way.

New AI-Powered Model Improves Skin Disease Diagnosis

The model integrates four key types of imagery: total-body photographs, standard clinical photos, dermoscopic close-ups, and dermatopathology slides.

Enhancing GIST Patient Care: The Importance of Collaborating with Sarcoma Centres

This series of short videos features expert opinions regarding the management of gastrointestinal stromal tumors (GIST). Each expert…

Bridging Borders in Women’s Health

This week, the host Saranya Ravindran welcomes Tommaso Falcone, reproductive health pioneer and global healthcare leader. From redefining…

Mood Symptoms Linked to Poorer Progressive Supranuclear Palsy Outcomes

Depression and anxiety, not motor decline, are the strongest predictors of quality of life in patients with progressive supranuclear palsy (PSP), according to a new study that underscores the pressing need for comprehensive symptom management beyond traditional motor assessments.

Why Female Shift Workers Face Higher Asthma Risk

Female night shift workers may face a significantly increased risk of developing asthma, according to a new study that analyzed data from more than 280,000 participants.

The Rise of Onco-Rheumatology: A New Era Begins

As cancer therapies evolve and autoimmune diseases become more prevalent, the intersection of oncology and rheumatology, onco-rheumatology, is emerging as a critical field demanding transdisciplinary care.